Previous 10 | Next 10 |
Estimates from the United Nations show that about 363 million individuals worldwide are affected by humanitarian crises driven by the climate crisis, increase conflict and fragility, and broadening inequality. In 2022, more than 108 million individuals were forced to flee their homes due to c...
2024-01-30 16:29:25 ET More on Scinai Immunotherapeutics Scinai Immunotherapeutics to raise $1.7M through exercise of outstanding warrants Seeking Alpha’s Quant Rating on Scinai Immunotherapeutics Read the full article on Seeking Alpha For further deta...
La Jolla Institute for Immunology (LJI) scientists have uncovered a critical T-cell in children’s brains that could help fight pediatric brain tumors. The research team published a study in the journal “ Nature Cancer” outlining how the cancer-killing T cells may already b...
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products, is congratulating its colead scientific research collaborator Professor Dr. Dirk Görlich, w...
Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet Prize PR Newswire JERUSALEM , Jan. 25, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focu...
Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds PR Newswire JERUSALEM , Jan. 4, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), a biopharmaceutical company focused both on...
Scinai Immunotherapeutics CEO Issues Letter to Shareholders PR Newswire JERUSALEM , Jan. 4, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I) biologica...
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on developing, manufacturing and commercializing innovative inflammation and immunology (“I&I”) biological products and provision of boutique CDMO (“CDMO”) services, has entered a d...
2023-12-29 09:30:29 ET More on Scinai Immunotherapeutics Scinai Immunotherapeutics regains compliance with stockholders' equity rule Seeking Alpha’s Quant Rating on Scinai Immunotherapeutics Historical earnings data for Scinai Immunotherapeutics Financ...
Scinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross Proceeds PR Newswire JERUSALEM , Dec. 29, 2023 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused both on developme...
News, Short Squeeze, Breakout and More Instantly...
Scanner Technologies Corp Company Name:
SCNI Stock Symbol:
OTCMKTS Market:
Scanner Technologies Corp Website:
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biotechnology company focused on developing inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservic...
Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the PEI on the path for Phase 1/2a in Plaque Psoriasis with its anti-IL-17 nanoAb PR Newswire Scinai Immunotherapeutics Announces Positive Regulatory Feedback from the Paul Erlich Institute (the PEI) for its...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...